Trading Conditions

Platform
MT5
MT5
Execution
Market Execution
Market Execution
MT5Floating spreads
Minimum: 43.00Average: 43.49
Market Hours*Open Now
Market Hours*Open Now
TickerBIIB.O
Limit and Stop Level50
1 tick value per share0.01 USD
Minimum contract size0.01 share
CommissionNo
Minimum Price Fluctuation0.01 USD
Minimum step for increasing contract size0.01 share
Margin requirements to open a lock position *0
Maximum Trade Size1000
Maximum exposure per share per account, USD100 000

* Only if Margin Level > 100%

The average spreads provided for each platform are updated on a daily basis to reflect the average for the previous day. Though FxPro attempts to provide competitive spreads during all trading hours, clients should note that these may vary and are susceptible to underlying market conditions. The above is provided for indicative purposes only. Clients are advised to check important news announcements on our Economic Calendar, which may result in the widening of spreads, amongst other instances.

The above spreads are applicable under normal trading conditions. FxPro has the right to amend the above spreads according to market conditions as per the 'Terms and Conditions of Business'.

Explore the ever-changing world of Biogen Inc shares on FxPro. Get the latest information on the current share price, market performance, and economic insights. Understand Biogen Inc's market position with our comprehensive analysis, including historical data and future prospects. Stay updated about the latest market trends and how they impact Biogen Inc's share value. Begin trading with FxPro today and capitalize on the potential of Biogen Inc's shares in your investment portfolio.

Biogen Inc is a biotechnology company that develops and distributes medicines for patients with serious diseases in the field of neurology and the neuroimmune system. BIIB.O Laboratories have brought recognition to drugs for multiple sclerosis, Alzheimer's disease, dementia, Parkinson's disease and neuromuscular disorders, including muscular atrophy of the spine.

Recent developments include Aducanumab, approved for use since June 2021, for the treatment of Alzheimer's disease. Since the approval for use was obtained under an accelerated scheme, the company will continue its clinical trials to confirm the benefits of the drug and its mass use.

If you are convinced that biotechnology is the future, take a closer look at changes in the share price of Biogen Inc. This is one of the most talked-about companies in recent times. As an FxPro client, you can join the price fluctuations by making not only buy trades but also sell trades as a CFD.

On our platforms, including the native FxPro Trading Platform, you will find an online quote chart that you can analyse and use to place orders. We do not give specific recommendations in what direction it is worth opening trades since such a choice is the responsibility of each trader. However, you have convenient analytical tools at your disposal that can greatly facilitate decision making.

Experienced traders do not recommend making deals without a well-developed trading strategy tested on a demo account. Also, pay attention to news that may have an impact on the value of the company stocks and be sure to check the Dividend & Earnings Calendar on the FxPro website to be prepared for any dividend payments or company reports. It is also worth utilising technical indicators to help you assess the situation on the chart.

In addition, you can utilise our trading tools, such as Trading Central technical analysis, trading calculators, analytical articles and free education on the FxPro website.

We also recommend subscribing to the official FxPro Telegram channel and monitoring the FxPro News portal to quickly receive the latest analytics and keep on top of what is happening on the markets.

Start Trading BIIB.O CFD Stocks with FxPro Today!